EARNING RECAP

Intuitive Surgical Inc

#ISRG 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 $3.25 est. $2.87 $1.1B est. $1.03B -1.46% ($528.81 closing price0 $544.85 $525.37 worldwide sales of DaVinci grew approx. 17%;
Q1 $2.61 est. $2.70 $974M est. $973.43M -7.01% ($491.06 closing price) $505.87 $486.66 says worldwide da Vinci procedures grew 18%; shipped 235 da Vinci surgical systems an increase of 18% comapred to Q1 of 2018; tightens FY19 procedure growth view to 15%-17% from 13%-17%
#ISRG 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $2.96 est. $3.07 $1.05B est. $1.04B -3.93% ($515.04 closing price) $525.90 $508.83 sees Fy19 procedure growth 13%-17%;
Q3 $2.83 est. $2.66 $921M est. $917.09 na na na raises Fy18 procedure growth view to17%-18% from 14.5%-16.5%
Q2 $2.76 vs $2.50 $909M vs $877.56M -0.87% $538.98 $516.35 The company shipped 220 da Vinci Surgical Systems compared with 166 in the 2Q 2017
Q1 $2.44 est. $2.09 $848M est. $783.28 +8.17% ($471.03 closing) $473.79 $448.91 Q1 procedure growth was driven by general surgery, reaffirms FY18 gross prfoitof 70%- 71.5%
#ISRG 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $2.54 Vs $2.27 $892M vs $550.6M -2.13% $440.25 $417.00 says 2017 growth driven by hernia repair. Sees 2018 gorss profit margin 70%-71.5%
Q3 $2.77 Vs $1.99 $806M vs $753.15M +3.39% ($369.58 closing) $374.89 $356.91 raises FY17 procedure growth view to 15%-16%, from 14%-15%
Q2 $5.05 vs $4.86 $397.8M vs $390.1M -4.55% ( $927.47 closing) $967.97 $925.70
Q1 $5.09 vs $4.95 $674 vs $666.54 +6.37% ($807.70 closing) $817.20 $790.98 Rev Q1 up 4%. Stock gapped at open, but close with doji candle sell at end of day.

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.